182 related articles for article (PubMed ID: 34861338)
41. Self-Sampling as a Plausible Alternative to Screen Cervical Cancer Precursor Lesions in a Population with Low Adherence to Screening: A Systematic Review.
Caleia AI; Pires C; Pereira JF; Pinto-Ribeiro F; Longatto-Filho A
Acta Cytol; 2020; 64(4):332-343. PubMed ID: 31958789
[TBL] [Abstract][Full Text] [Related]
42. Cervical Cancer Screening-Past, Present, and Future.
Wentzensen N; Clarke MA
Cancer Epidemiol Biomarkers Prev; 2021 Mar; 30(3):432-434. PubMed ID: 33857013
[TBL] [Abstract][Full Text] [Related]
43. Barriers to HPV self-sampling and cytology among low-income indigenous women in rural areas of a middle-income setting: a qualitative study.
Allen-Leigh B; Uribe-Zúñiga P; León-Maldonado L; Brown BJ; Lörincz A; Salmeron J; Lazcano-Ponce E
BMC Cancer; 2017 Nov; 17(1):734. PubMed ID: 29121873
[TBL] [Abstract][Full Text] [Related]
44. High-risk human papillomavirus detection in self-sampling compared to physician-taken smear in a responder population of the Dutch cervical screening: Results of the VERA study.
Ketelaars PJW; Bosgraaf RP; Siebers AG; Massuger LFAG; van der Linden JC; Wauters CAP; Rahamat-Langendoen JC; van den Brule AJC; IntHout J; Melchers WJG; Bekkers RLM
Prev Med; 2017 Aug; 101():96-101. PubMed ID: 28579497
[TBL] [Abstract][Full Text] [Related]
45. Results of a Pilot Study of a Mail-Based Human Papillomavirus Self-Testing Program for Underscreened Women From Appalachian Ohio.
Reiter PL; Shoben AB; McDonough D; Ruffin MT; Steinau M; Unger ER; Paskett ED; Katz ML
Sex Transm Dis; 2019 Mar; 46(3):185-190. PubMed ID: 30461597
[TBL] [Abstract][Full Text] [Related]
46. A pilot study of community-based self-sampling for HPV testing among non-attenders of cervical cancer screening programs in El Salvador.
Laskow B; Figueroa R; Alfaro KM; Scarinci IC; Conlisk E; Maza M; Chang JC; Cremer M
Int J Gynaecol Obstet; 2017 Aug; 138(2):194-200. PubMed ID: 28589548
[TBL] [Abstract][Full Text] [Related]
47. Recent HPV self-sampling use for cervical cancer screening in Latin America and Caribbean: a systematic review.
Dartibale CB; Prado GC; Carobeli LR; Meirelles LEF; Damke GMZF; Damke E; Morelli F; Souza RP; ; da Silva VRS; Consolaro MEL
Front Oncol; 2022; 12():948471. PubMed ID: 36338730
[TBL] [Abstract][Full Text] [Related]
48. Cervical Cancer Screening with Human Papillomavirus Self-Sampling Among Transgender Men in El Salvador.
Maza M; Meléndez M; Herrera A; Hernández X; Rodríguez B; Soler M; Alfaro K; Masch R; Conzuelo-Rodríguez G; Obedin-Maliver J; Cremer M
LGBT Health; 2020; 7(4):174-181. PubMed ID: 32407149
[No Abstract] [Full Text] [Related]
49. Comparison between professional sampling and self-sampling for HPV-based cervical cancer screening among postmenopausal women.
Bergengren L; Kaliff M; Larsson GL; Karlsson MG; Helenius G
Int J Gynaecol Obstet; 2018 Sep; 142(3):359-364. PubMed ID: 29856071
[TBL] [Abstract][Full Text] [Related]
50. Comparison of use of vaginal HPV self-sampling and offering flexible appointments as strategies to reach long-term non-attending women in organized cervical screening.
Darlin L; Borgfeldt C; Forslund O; Hénic E; Hortlund M; Dillner J; Kannisto P
J Clin Virol; 2013 Sep; 58(1):155-60. PubMed ID: 23867008
[TBL] [Abstract][Full Text] [Related]
51. The potential role of self-sampling for high-risk human papillomavirus detection in cervical cancer screening.
Schmeink CE; Bekkers RL; Massuger LF; Melchers WJ
Rev Med Virol; 2011 May; 21(3):139-53. PubMed ID: 21538664
[TBL] [Abstract][Full Text] [Related]
52. Accuracy of dry vaginal self-sampling for detecting high-risk human papillomavirus infection in cervical cancer screening: a cross-sectional study.
Haguenoer K; Giraudeau B; Gaudy-Graffin C; de Pinieux I; Dubois F; Trignol-Viguier N; Viguier J; Marret H; Goudeau A
Gynecol Oncol; 2014 Aug; 134(2):302-8. PubMed ID: 24905772
[TBL] [Abstract][Full Text] [Related]
53. Cervical Human Papillomavirus Testing With Two Home Self-Collection Methods Compared With a Standard Clinically Collected Sampling Method.
McLarty JW; Williams DL; Loyd S; Hagensee ME
Sex Transm Dis; 2019 Oct; 46(10):670-675. PubMed ID: 31517806
[TBL] [Abstract][Full Text] [Related]
54. The acceptability of self-sampled screening for HPV DNA: a systematic review and meta-analysis.
Nelson EJ; Maynard BR; Loux T; Fatla J; Gordon R; Arnold LD
Sex Transm Infect; 2017 Feb; 93(1):56-61. PubMed ID: 28100761
[TBL] [Abstract][Full Text] [Related]
55. Self-collecting a cervico-vaginal specimen for cervical cancer screening: an exploratory study of acceptability among medically underserved women in rural Appalachia.
Vanderpool RC; Jones MG; Stradtman LR; Smith JS; Crosby RA
Gynecol Oncol; 2014 Mar; 132 Suppl 1(0 1):S21-5. PubMed ID: 24125753
[TBL] [Abstract][Full Text] [Related]
56. Human Papilloma Virus (HPV) self-sampling: do women accept it?
Abdullah NN; Daud S; Wang SM; Mahmud Z; Mohd Kornain NK; Al-Kubaisy W
J Obstet Gynaecol; 2018 Apr; 38(3):402-407. PubMed ID: 29385850
[TBL] [Abstract][Full Text] [Related]
57. Resilience of the Dutch HPV-based cervical screening programme during the COVID-19 pandemic.
Olthof EMG; Aitken CA; Siebers AG; van Kemenade FJ; de Kok IMCM
Public Health; 2024 Feb; 227():42-48. PubMed ID: 38103276
[TBL] [Abstract][Full Text] [Related]
58. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
[TBL] [Abstract][Full Text] [Related]
59. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
[TBL] [Abstract][Full Text] [Related]
60. Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis.
Bruni L; Serrano B; Roura E; Alemany L; Cowan M; Herrero R; Poljak M; Murillo R; Broutet N; Riley LM; de Sanjose S
Lancet Glob Health; 2022 Aug; 10(8):e1115-e1127. PubMed ID: 35839811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
